Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Carboplatin and Paclitaxel in Advanced or Recurrent Cervical Cancer
NCT00997009Phase 2Unknown
- Sponsor
- National Cancer Institute
- Start
- Oct 2009
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in Cervical Cancer (CC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
KL-140
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00997009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997009.